Pascal Reber
Chairman chez Entreprendre Pour Apprendre /Rhone Alpes/
Profil
Pascal Reber is currently the Chairman and Treasurer at Entreprendre Pour Apprendre.
Previously, he held positions as Chairman-Supervisory Board at Amoéba SA, Chairman at Association Des Fabricants De L’Industrie Pharmaceutique De RA, and Vice President & General Director at Genzyme Corp.
He obtained an undergraduate degree from Ecole Nationale d'Ingénieurs de Metz.
Postes actifs de Pascal Reber
Sociétés | Poste | Début |
---|---|---|
Entreprendre Pour Apprendre /Rhone Alpes/ | Chairman | - |
Entreprendre Pour Apprendre | Treasurer | - |
Anciens postes connus de Pascal Reber
Sociétés | Poste | Fin |
---|---|---|
AMOÉBA | Chairman | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Association Des Fabricants De L’Industrie Pharmaceutique De RA | Chairman | - |
Formation de Pascal Reber
Ecole Nationale d'Ingénieurs de Metz | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMOÉBA | Consumer Non-Durables |
Entreprise privées | 4 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Entreprendre Pour Apprendre | |
Entreprendre Pour Apprendre /Rhone Alpes/ | |
Association Des Fabricants De L’Industrie Pharmaceutique De RA |